Ginkgo Bioworks Holdings (DNA) Intangibles (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) reported Intangibles of $48.9 million for Q1 2026, down 28.94% on a YoY basis from $68.8 million in Q1 2025, and down 8.64% quarter-over-quarter from $53.5 million in Q4 2025.
Ginkgo Bioworks Holdings (DNA) Intangibles (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings has reported Intangibles for 7 years, with the latest figure at $48.9 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles fell 28.94% year-over-year to $48.9 million; the trailing twelve-month figure through Mar 2026 stood at $48.9 million (down 28.94% YoY), and the FY2025 full-year result was $53.5 million, down 26.24% from the prior year.
- Intangibles for Q1 2026 stood at $48.9 million, down from $53.5 million in the prior quarter.
- The five-year high for Intangibles was $111.0 million in Q4 2022, with the low at $20.8 million in Q1 2022.
- Historically, Intangibles has averaged $72.6 million across 5 years, with a median of $72.5 million in 2024.
- Annual changes were most pronounced in 2023 — Intangibles jumped 422.04% — and 2026, when it dropped 28.94%.
- Ginkgo Bioworks Holdings' Intangibles stood at $111.0 million in 2022, then retreated by 25.49% to $82.7 million in 2023, then decreased by 12.37% to $72.5 million in 2024, then slipped by 26.24% to $53.5 million in 2025, then decreased by 8.64% to $48.9 million in 2026.
- The last three Intangibles figures came in at $48.9 million (Q1 2026), $53.5 million (Q4 2025), and $61.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Ginkgo Bioworks Holdings | 546.79 Mn | 546.79 Mn | 16.38 Mn | 48.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.86 Mn |
| Dec 31, 2025 | 53.48 Mn |
| Sep 30, 2025 | 61.52 Mn |
| Jun 30, 2025 | 66.15 Mn |
| Mar 31, 2025 | 68.76 Mn |
| Dec 31, 2024 | 72.51 Mn |
| Sep 30, 2024 | 79.57 Mn |
| Jun 30, 2024 | 90.60 Mn |
| Mar 31, 2024 | 77.41 Mn |
| Dec 31, 2023 | 82.74 Mn |
| Sep 30, 2023 | 100.17 Mn |
| Jun 30, 2023 | 105.03 Mn |
| Mar 31, 2023 | 108.74 Mn |
| Dec 31, 2022 | 111.04 Mn |
| Sep 30, 2022 | 47.94 Mn |
| Jun 30, 2022 | 39.18 Mn |
| Mar 31, 2022 | 20.83 Mn |
| Dec 31, 2021 | 21.64 Mn |
| Sep 30, 2021 | 22.57 Mn |
| Dec 31, 2020 | 3.29 Mn |